Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01477463 · ClinicalTrials.gov registry record · NA
Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01477463: Completed NA study, sponsored by Stanford University.
NCT01477463 is a NA study that has completed, run by Stanford University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01477463, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the signaling pathways and changes in gene expression in melanocytes of subjects with a history of non-melanoma skin cancer who are exposed to oral vitamin D. If vitamin D is found to inhibit a signaling pathway involved in the development of melanoma such as BRAF, a protein involved in cell proliferation, then oral vitamin D could be explored further as a chemoprevention for melanoma skin cancer.
Interventions
- DRUG Vitamin D3
- DRUG placebo and vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01477463
The ClinicalTrials.gov registry entry for NCT01477463 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 is the first listed.
NCT01477463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01477463 about?
NCT01477463 is a clinical study titled "Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers". The purpose of this study is to determine the signaling pathways and changes in gene expression in melanocytes of subjects with a history of non-melanoma skin cancer who are exposed to oral vitamin D. If vitamin D is found to inhibit a signaling pathway involved in the development of melanoma such a...
What is the current status of trial NCT01477463?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2012-09. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01477463?
The interventions under investigation include: Vitamin D3 (DRUG), placebo and vitamin D (DRUG).
Who is sponsoring clinical trial NCT01477463?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.